MEGAN LUNSFORD: Open Payments
NPI 1063811560 · GALLIPOLIS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 38 payments from 11 companies in 2025. Trend: 2023 $375 · 2024 $508 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $356 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $111 |
| Novo Nordisk Inc | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Dexcom, Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| CeQur Corporation | 1 | $14 |
Products named: QULIPTA, Kerendia, UBRELVY, VRAYLAR, AIRSUPRA, Dexcom G6 Transmitter, ULTOMIRIS, LEQVIO.
Industry payments across OH — which companies pay providers there.
